% Bio-Based Products Business4/ 339 510 -34% 136 150% 848 330 157% Natural Resources Business5/ 60 (1,227) 105% 145 -59% (1,166) 122 N/A Others (71) (90) 22% (94) 25% (161) (170) 5% Profit attributable to
, including media and telecommunication business, technology business and others. In addition to his business management experience, he also held positions in governmental agencies such as Executive Council of
1 August 17, 2018 Subject: Capital Increase for Offering for Sale to Specific Investors (Private Placement), Connected Transaction, Amendments to Articles of Association/Objectives of the Company and Determination of the Date of Extraordinary General Meeting of Shareholders No. 1/2018 To: President The Stock Exchange of Thailand Enclosures: 1. Information Memorandum on the Offering of Newly Issued Ordinary Shares to Specific Investors (Private Placement) at the Offering Price with a Discount of...
% อื่นๆ 2.53% Biotechnology, 35.20% Health Care Equipment & Supplies, 33.80% Life Sciences Tools & Services, 14.90% Health Care Technology, 11.10% Pharmaceuticals, 3.30% Others, 0.80% Cash, 0.80% LHHEALTH-A
JV 13 7 80% (2) 6 (0) 3,284% Others (FiberVisions, PHP China, Mexico) 1 5 (75)% 0 0 1 (84)% 1 74% PTA JV, IVL started consolidating Polyprima Indonesia result since 4Q18. IVL has 100% ownership since
of operating results for the year 2019, Ended of December 31, 2019 Unit : Million Baht Power Generation Others Total Change Increase (Decrease) 2019 2018 2019 2018 2019 2018 Amount % Total Revenues
Export Sales 100.0% 22.3% 30.4% -8.5% 5.6% 149.7% 1,481 44.1% CBD 96.0% ICUK 4.0% CLMV 65.6% China 20.3% Afghanistan & Yemen 9.6% UK and Outside Asia 4.0%Others, 0.5% Note: Pie charts represent annual
responsibility and shall not be liable for the non-compliance with applicable rules and regulations regarding, among others but not limited to, the marketing of financial instruments by a product provider, a
lent out and collateral shall include the following details: (a) the lender has to transfer the securities without preferential right or any encumbrance of others to the borrower, and the borrower has to
collateral shall include the following details: (a) the lender has to transfer the securities without preferential right or any encumbrance of others to the borrower, and the borrower has to pledge asset as